BASTA JAMES 4
4 · Intellia Therapeutics, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
BASTA JAMES
EVP, General Counsel
Transactions
- Award
Common Stock
2024-03-01+32,394→ 83,868 total - Sale
Common Stock
2024-03-04$32.99/sh−2,297$75,778→ 81,571 total - Award
Stock Option (right to buy)
2024-03-01+46,752→ 46,752 totalExercise: $32.66Exp: 2034-02-28→ Common Stock (46,752 underlying)
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2024, and does not represent a volitional trade by the Reporting Person.
- [F3]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.